Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine for Omphalitis Prevention in Pakistan
NCT00682006Phase 3Completed
- Sponsor
- Aga Khan University
- Start
- Jan 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorhexidine in omphalitis (4 arms), sponsored by Aga Khan University. Primary endpoints: Incidence of Neonatal Omphalitis and Rate of Neonatal Mortality. Started Jan 2008; status: completed.
02
Drugs
chlorhexidine
03
Conditions
omphalitis
Beyond the preview
Go deeper on NCT00682006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682006.